PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
32946839-6	2020	Treatment with DL-2-difluoromethylornithine (DFMO), an inhibitor of polyamine biosynthesis, diminished GATA3 expression in CD4+ T cells under Th2-skewed conditions.	dl-2-difluoromethylornithine	15-43	GATA binding protein 3	Mus musculus	103-108
2500977-1	1989	LLC-PK1 cells were brought to a quiescent state by treatment with DL-2-difluoromethylornithine (DFMO), a specific inhibitor of L-ornithine decarboxylase (ODC).	dl-2-difluoromethylornithine	66-94	ornithine decarboxylase 1	Sus scrofa	127-152
2500977-1	1989	LLC-PK1 cells were brought to a quiescent state by treatment with DL-2-difluoromethylornithine (DFMO), a specific inhibitor of L-ornithine decarboxylase (ODC).	dl-2-difluoromethylornithine	66-94	ornithine decarboxylase 1	Sus scrofa	154-157
3937520-0	1985	Gene expression of ornithine decarboxylase in L1210 leukaemia cells exposed to DL-2-difluoromethylornithine in the presence of cadaverine.	dl-2-difluoromethylornithine	79-107	ornithine decarboxylase, structural 1	Mus musculus	19-42
3937520-1	1985	Cultured mouse L1210 leukaemia cells treated with DL-2-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase (EC 4.1.1.17), in the presence of micromolar concentrations of cadaverine, started to overproduce ornithine decarboxylase after an exposure of several weeks.	dl-2-difluoromethylornithine	50-78	ornithine decarboxylase, structural 1	Mus musculus	109-132
3937520-1	1985	Cultured mouse L1210 leukaemia cells treated with DL-2-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase (EC 4.1.1.17), in the presence of micromolar concentrations of cadaverine, started to overproduce ornithine decarboxylase after an exposure of several weeks.	dl-2-difluoromethylornithine	50-78	ornithine decarboxylase, structural 1	Mus musculus	231-254
32946839-6	2020	Treatment with DL-2-difluoromethylornithine (DFMO), an inhibitor of polyamine biosynthesis, diminished GATA3 expression in CD4+ T cells under Th2-skewed conditions.	dl-2-difluoromethylornithine	15-43	CD4 antigen	Mus musculus	123-126